1. Home
  2. KALV vs TWI Comparison

KALV vs TWI Comparison

Compare KALV & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • TWI
  • Stock Information
  • Founded
  • KALV N/A
  • TWI 1890
  • Country
  • KALV United States
  • TWI United States
  • Employees
  • KALV N/A
  • TWI N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • TWI Steel/Iron Ore
  • Sector
  • KALV Health Care
  • TWI Industrials
  • Exchange
  • KALV Nasdaq
  • TWI Nasdaq
  • Market Cap
  • KALV 642.3M
  • TWI 590.5M
  • IPO Year
  • KALV N/A
  • TWI 1993
  • Fundamental
  • Price
  • KALV $14.31
  • TWI $10.26
  • Analyst Decision
  • KALV Strong Buy
  • TWI Strong Buy
  • Analyst Count
  • KALV 9
  • TWI 2
  • Target Price
  • KALV $26.29
  • TWI $11.00
  • AVG Volume (30 Days)
  • KALV 2.0M
  • TWI 623.9K
  • Earning Date
  • KALV 07-10-2025
  • TWI 07-31-2025
  • Dividend Yield
  • KALV N/A
  • TWI N/A
  • EPS Growth
  • KALV N/A
  • TWI N/A
  • EPS
  • KALV N/A
  • TWI N/A
  • Revenue
  • KALV N/A
  • TWI $1,854,436,000.00
  • Revenue This Year
  • KALV N/A
  • TWI $2.17
  • Revenue Next Year
  • KALV $347.19
  • TWI $5.25
  • P/E Ratio
  • KALV N/A
  • TWI N/A
  • Revenue Growth
  • KALV N/A
  • TWI 5.64
  • 52 Week Low
  • KALV $7.30
  • TWI $5.93
  • 52 Week High
  • KALV $16.32
  • TWI $10.94
  • Technical
  • Relative Strength Index (RSI)
  • KALV 58.58
  • TWI 61.60
  • Support Level
  • KALV $11.10
  • TWI $10.06
  • Resistance Level
  • KALV $16.32
  • TWI $10.60
  • Average True Range (ATR)
  • KALV 1.10
  • TWI 0.46
  • MACD
  • KALV 0.36
  • TWI -0.04
  • Stochastic Oscillator
  • KALV 68.95
  • TWI 70.76

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: